Brief: Dicot Pharma Gets Conditional Approval For Listing On Nasdaq First North Growth Market
Oct 23 (Reuters) - Dicot Pharma AB DICOT.TE :
* CONDITIONAL APPROVAL FOR LISTING ON NASDAQ FIRST NORTH
GROWTH
MARKET
* PRELIMINARY FIRST DAY OF TRADING NOVEMBER 7
Source text for Eikon: ID:nWkrbBC7T4
Further company coverage: DICOT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue
Brief: Dicot Pharma Announces Prelim Rights Issue Outcome
Brief: Dicot Pharma Submits IND Application To FDA